Clinical Trial Update: Dutasteride With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS) [Phase 4]

View source ↗

Summary

Phase 4 trial assessed dutasteride with tolterodine ER versus placebo for lower urinary tract symptoms in men with benign prostatic hyperplasia; results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• DUTASTERIDE (Dutasteride)
• Tolterodine ER (tolterodine tartrate (extended-release))

Snippet

Sponsor: Siami, Paul F., M.D. | Conditions: Benign Prostatic Hyperplasia (BPH) | Phase 4 | Status: COMPLETED | Results posted: 2015-05-01